Bayer asks judge in second glyphosate-cancer case to restrict evidence to be presented against Monsanto

monsantolaw
Credit: Jersey City

Bayer AG unit Monsanto has asked a California judge in the litigation over its glyphosate-based weed killer Roundup allegedly causing cancer to limit evidence by splitting an upcoming trial into two phases, a request previously successful with another judge.

Monsanto in a previously unreported filing on Jan. 15 asked California Superior Court Judge Winifred Smith in Oakland to split a March trial by a California couple into two phases.

Such a step would limit evidence the plaintiffs in the litigation consider crucial to their cases and describe as critical to a jury last year awarding $289 million in a similar case.

Under the company’s proposal, lawyers for Alva and Alberta Pilliod in the initial trial phase would be barred from introducing evidence that the company allegedly attempted to influence regulators and manipulate public opinion.

Such evidence would be allowed only if glyphosate was found to have caused the Pilliods’ cancer and the trial proceeded to a second phase to determine the company’s liability.

U.S. District Judge Vince Chhabria in San Francisco, who oversees the federal Roundup litigation with some 680 cases pending before him, on Jan. 3 approved the company’s request to initially limit evidence in upcoming trials before him.

Read full, original article: BAYER ASKS CALIFORNIA JUDGE TO LIMIT EVIDENCE IN ANOTHER ROUNDUP CANCER TRIAL

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2025-09-17 at 12.41
Misinformation alert: No, glyphosate use in Canadian forests is not spurring more wildfires
ChatGPT-Image-Jul-9-2026-02_39_22-PM
Viewpoint: Polyphenols or NAD+ supplements to combat aging: No, Gwenyth Paltrow and followers, don’t waste your money.
file-f-d-d-
Facts & Fallacies Podcast: Europe's AC debacle underscores fatal flaw in green activism
ChatGPT-Image-Jul-8-2026-12_32_48-PM
Viewpoint: SCOTUS strikes a blow against junk science in Bayer glyphosate case. Will it deter mass tort litigators?
Screenshot 2026-07-11 094410
Growing animal muscle and fat cells inside rice grains and calling it beef: One of numerous genetically engineered products shaking up our ecosystem
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
afb-a-b
As the EU loosens restrictions on agricultural gene editing, it remains years behind the rest of the world on equally-safe GMO foods
ChatGPT-Image-Jul-7-2026-01_57_55-PM
Viewpoint: Europe’s rejection of air conditioning is the poster child for misunderstanding how to mitigate the impact of climate change
ChatGPT-Image-Jul-6-2026-02_25_26-PM
40 million Americans take glucosamine. If you have memory loss, it could accelerate cognitive decline.
ChatGPT-Image-Jul-1-2026-03_33_49-PM
‘Alternative’ cancer treatments that could kill you
ChatGPT-Image-Jun-17-2026-03_29_08-PM
Viewpoint: What’s the impact of the U.S. abandoning support for global health?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.